Search

everythinglearnresearchcommunity

for

Search:↓

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

Allium hookeri extract may help promote hair growth and protect cells from damage.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

ROOT HAIR SPECIFIC 10 (RHS10) reduces the length of root hairs in Arabidopsis plants.

SGK3 is essential for proper hair growth and health.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Ruxolitinib treatment may cause eyelash growth.

JAK inhibitors effectively treat skin conditions and topical forms are safer.

Newborn mouse skin cells can grow hair and this process can be recreated in adult cells to potentially help with hair loss.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Human hair follicles have a unique metabolism that changes between growth stages and may contribute to baldness.

Stem cells could improve hair growth and new treatments for baldness are being researched.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

Angelica gigas Nakai root extracts may help with cancer, pain, memory loss, and metabolic issues.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

JAK inhibitors offer new hope for treating severe alopecia areata.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

Sunlight exposure improved a patient's skin condition, and there may be a link between a certain disease and skin growths; a leukemia treatment caused changes in hair color and growth.